Dr. Surks is a physician-scientist with a background in translational medicine and early clinical development, basic cardiovascular research and clinical cardiology. Dr. Surks was most recently [...]
Mr. Lawrence joined Cardurion as President, Chief Executive Officer and a board member in March of 2020. Mr. Lawrence brings more than 20 years of experience as a life sciences executive and [...]
Dr. Shota Ikeda is the Head of Cardurion KK, Cardurion’s Japanese Subsidiary and Executive Director, Drug Discovery, responsible for all scientific and administrative activities of Cardurion KK. [...]
Amy Schulman is a managing partner of Polaris Partners in the New York office and focuses on investments in healthcare companies. She currently serves as executive chair of SQZ Biotech, as well [...]
Silvia G. Priori, M.D., Ph.D. is full professor of Cardiology in the Department of Molecular Medicine at the University of Pavia and director of the Cardiology Division at the Istituti Clinici [...]
Jeb Keiper is the chief executive officer and president of Nimbus Therapeutics, a biotechnology company harnessing quantum mechanics and computational approaches to structural biology to design [...]
